Abstract
Ultrasound-mediated drug delivery is a promising means of enhancing delivery, distribution and effectiveness of drugs within tumours. In this review, prospects for exploiting ultrasound to improve the tumour delivery and distribution of radiolabelled antibodies for radioimmunotherapy and to overcome barriers imposed by tumour microenvironment are discussed.
Original language | English |
---|---|
Article number | N/A |
Pages (from-to) | N/A |
Number of pages | 6 |
Journal | JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS |
Volume | N/A |
Issue number | N/A |
DOIs | |
Publication status | E-pub ahead of print - 2013 |